Prokineticin 1 Protein (Prok1)

Produktnummer ABIN935328

Dieses Recombinant Prokineticin 1-Protein wird in Escherichia coli (E. coli) exprimiert.

Kurzübersicht für Prokineticin 1 Protein (Prok1) (ABIN935328)

Target: Prokineticin 1 (Prok1)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Reinheit: > 97 % pure

Produktdetails

Produktmerkmale: Purified recombinant Human EG VEGF protein
Expression System: E.coli

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in distilled water to a concentration > 0.1 mg/mL.

Buffer: Supplied lyophilized from a concentrated (1 mg/mL) solution, with no additives.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: Prokineticin 1 (Prok1)

Andere Bezeichnung: EG VEGF

Hintergrund: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types.
Alternative Names: PK1 protein, Endocrine Gland-derived Vascular Endothelial Growth Factor protein, PRK1 protein, EG-VEGF protein, Prokineticin 1 protein